Use of ziprasidone in parkinsonian patients with psychosis.
2005
Abstract:Twelve patients with Parkinson disease and psychosis were included in an open-label 12-week trial of ziprasidone. Two patients withdrew from the treatment because of adverse effects. The remaining 10 patients reported a significant improvement in psychiatric symptoms. Altogether, there was
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
31
References
57
Citations
NaN
KQI